Drug Profile
Research programme: PPAR alpha/gamma agonists - Bayer
Alternative Names: PPAR alpha/gamma activators research programme - Bayer; Research programme: PPAR alpha/gamma activators - Bayer; Research programme: PPAR gamma/alpha activators - BayerLatest Information Update: 25 Aug 2003
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 25 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Germany (unspecified route)
- 23 Oct 2001 Preclinical development for Type-2 diabetes mellitus in Germany (Unknown route)